322 related articles for article (PubMed ID: 34928079)
1. Stratified 3D Microtumors as Organotypic Testing Platforms for Screening Pancreatic Cancer Therapies.
Monteiro MV; Gaspar VM; Mendes L; Duarte IF; Mano JF
Small Methods; 2021 May; 5(5):e2001207. PubMed ID: 34928079
[TBL] [Abstract][Full Text] [Related]
2. In-air production of 3D co-culture tumor spheroid hydrogels for expedited drug screening.
Antunes J; Gaspar VM; Ferreira L; Monteiro M; Henrique R; Jerónimo C; Mano JF
Acta Biomater; 2019 Aug; 94():392-409. PubMed ID: 31200118
[TBL] [Abstract][Full Text] [Related]
3. Generation of an in vitro 3D PDAC stroma rich spheroid model.
Ware MJ; Keshishian V; Law JJ; Ho JC; Favela CA; Rees P; Smith B; Mohammad S; Hwang RF; Rajapakshe K; Coarfa C; Huang S; Edwards DP; Corr SJ; Godin B; Curley SA
Biomaterials; 2016 Nov; 108():129-42. PubMed ID: 27627810
[TBL] [Abstract][Full Text] [Related]
4. Hydrogel 3D in vitro tumor models for screening cell aggregation mediated drug response.
Monteiro MV; Gaspar VM; Ferreira LP; Mano JF
Biomater Sci; 2020 Mar; 8(7):1855-1864. PubMed ID: 32091033
[TBL] [Abstract][Full Text] [Related]
5. Biomaterial substrate-derived compact cellular spheroids mimicking the behavior of pancreatic cancer and microenvironment.
Wong CW; Han HW; Tien YW; Hsu SH
Biomaterials; 2019 Aug; 213():119202. PubMed ID: 31132644
[TBL] [Abstract][Full Text] [Related]
6. Organotypic 3D decellularized matrix tumor spheroids for high-throughput drug screening.
Ferreira LP; Gaspar VM; Mendes L; Duarte IF; Mano JF
Biomaterials; 2021 Aug; 275():120983. PubMed ID: 34186236
[TBL] [Abstract][Full Text] [Related]
7. A bioengineered heterotypic stroma-cancer microenvironment model to study pancreatic ductal adenocarcinoma.
Drifka CR; Eliceiri KW; Weber SM; Kao WJ
Lab Chip; 2013 Oct; 13(19):3965-75. PubMed ID: 23959166
[TBL] [Abstract][Full Text] [Related]
8. Bioengineered tumoral microtissues recapitulate desmoplastic reaction of pancreatic cancer.
Brancato V; Comunanza V; Imparato G; Corà D; Urciuolo F; Noghero A; Bussolino F; Netti PA
Acta Biomater; 2017 Feb; 49():152-166. PubMed ID: 27916739
[TBL] [Abstract][Full Text] [Related]
9. Programmable Living Units for Emulating Pancreatic Tumor-Stroma Interplay.
Monteiro MV; Rocha M; Gaspar VM; Mano JF
Adv Healthc Mater; 2022 Jul; 11(13):e2102574. PubMed ID: 35426253
[TBL] [Abstract][Full Text] [Related]
10. 3D collagen fibrillar microstructure guides pancreatic cancer cell phenotype and serves as a critical design parameter for phenotypic models of EMT.
Puls TJ; Tan X; Whittington CF; Voytik-Harbin SL
PLoS One; 2017; 12(11):e0188870. PubMed ID: 29190794
[TBL] [Abstract][Full Text] [Related]
11. Viscoelastic properties of human pancreatic tumors and in vitro constructs to mimic mechanical properties.
Rubiano A; Delitto D; Han S; Gerber M; Galitz C; Trevino J; Thomas RM; Hughes SJ; Simmons CS
Acta Biomater; 2018 Feb; 67():331-340. PubMed ID: 29191507
[TBL] [Abstract][Full Text] [Related]
12. Design of spherically structured 3D in vitro tumor models -Advances and prospects.
Ferreira LP; Gaspar VM; Mano JF
Acta Biomater; 2018 Jul; 75():11-34. PubMed ID: 29803007
[TBL] [Abstract][Full Text] [Related]
13. Multiplex quantitative analysis of stroma-mediated cancer cell invasion, matrix remodeling, and drug response in a 3D co-culture model of pancreatic tumor spheroids and stellate cells.
Hwang HJ; Oh MS; Lee DW; Kuh HJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):258. PubMed ID: 31200779
[TBL] [Abstract][Full Text] [Related]
14. Microfluidic co-culture of pancreatic tumor spheroids with stellate cells as a novel 3D model for investigation of stroma-mediated cell motility and drug resistance.
Lee JH; Kim SK; Khawar IA; Jeong SY; Chung S; Kuh HJ
J Exp Clin Cancer Res; 2018 Jan; 37(1):4. PubMed ID: 29329547
[TBL] [Abstract][Full Text] [Related]
15. Thiol-ene hydrogels as desmoplasia-mimetic matrices for modeling pancreatic cancer cell growth, invasion, and drug resistance.
Ki CS; Lin TY; Korc M; Lin CC
Biomaterials; 2014 Dec; 35(36):9668-77. PubMed ID: 25176061
[TBL] [Abstract][Full Text] [Related]
16. FGF2 engineered SPIONs attenuate tumor stroma and potentiate the effect of chemotherapy in 3D heterospheroidal model of pancreatic tumor.
Mardhian DF; Vrynas A; Storm G; Bansal R; Prakash J
Nanotheranostics; 2020; 4(1):26-39. PubMed ID: 31911892
[TBL] [Abstract][Full Text] [Related]
17. FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro.
Mohamed AA; Thomsen A; Follo M; Zamboglou C; Bronsert P; Mostafa H; Amen A; Mekawy M; Grosu AL; Brunner TB
Strahlenther Onkol; 2021 Jan; 197(1):27-38. PubMed ID: 32705304
[TBL] [Abstract][Full Text] [Related]
18. Bioinstructive microparticles for self-assembly of mesenchymal stem Cell-3D tumor spheroids.
Ferreira LP; Gaspar VM; Mano JF
Biomaterials; 2018 Dec; 185():155-173. PubMed ID: 30245385
[TBL] [Abstract][Full Text] [Related]
19. 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing.
Longati P; Jia X; Eimer J; Wagman A; Witt MR; Rehnmark S; Verbeke C; Toftgård R; Löhr M; Heuchel RL
BMC Cancer; 2013 Feb; 13():95. PubMed ID: 23446043
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic cancer organotypics: High throughput, preclinical models for pharmacological agent evaluation.
Coleman SJ; Watt J; Arumugam P; Solaini L; Carapuca E; Ghallab M; Grose RP; Kocher HM
World J Gastroenterol; 2014 Jul; 20(26):8471-81. PubMed ID: 25024603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
